EUVIMEDEUVIMED entdecken
Open Access

Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes

Michael Fang, Yunwen Xu, Shoshana H Ballew, Josef Coresh, Justin B Echouffo-Tcheugui, Elizabeth Selvin, Jung-Im Shin

JAMA Network Open · 11.08.2025 · 8 (8) · e2526353

DOI: 10.1001/jamanetworkopen.2025.26353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 11.08.2025. Verfasst von Michael Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glycemic Control, Insulin Infusion Systems, Healthcare Disparities. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Characterizing population-level changes in type 1 diabetes (T1D) management can inform public health policies and interventions.

Objective

To characterize trends and disparities in glycemic control and use of diabetes technology among US youths and adults with T1D. Design, Setting, and Participants This serial, cross-sectional analysis used the Optum Labs Data Warehouse, a national, deidentified database of electronic health records, to identify US youths (aged <18 years) and adults (aged ≥18 years) with T1D. Data were obtained from records from January 1, 2009, to December 31, 2023. Exposures Calendar years divided into 3-year study periods from 2009 to 2011 to 2021 to 2023. Main Outcomes and Measures Glycemic control (mean hemoglobin A 1c level, <7%) and use of diabetes technology (continuous glucose monitoring systems and/or insulin pumps) were defined using laboratory data and prescriptions, procedures, and diagnoses codes from electronic health records.

Results

A total of 186 590 participants with T1D was identified (mean [SD] age, 40 [19] years; 96 766 [52%] male; 12 493 [7%] Hispanic, 2819 [2%] non-Hispanic Asian, 21 459 [12%] non-Hispanic Black, and 141 847 [76%] non-Hispanic White). Of these, 26 853 participants were youths (mean [SD] age, 12 [4] years; 14 060 [52%] male; 19 822 [74%] non-Hispanic White) and 159 737 were adults (mean [SD] age, 45 [16] years; 82 706 [52%] male; 122 025 [76%] non-Hispanic White). From the 2009-2011 to 2021-2023 study periods, the prevalence of glycemic control (mean hemoglobin A 1c level <7%) increased from 7% (95% CI, 7%-8%) to 19% (95% CI, 19%-20%) in youths ( P < .001 for trend) and 21% (95% CI, 21%-22%) to 28% (95% CI, 28%-29%) in adults ( P < .001 for trend). During this same period, there was a substantial increase in the percentage of patients using continuous glucose monitoring (4% to 82% for youths; 5% to 57% for adults), insulin pumps (16% to 50% for youths; 11% to 29% for adults), and both devices concurrently (1% to 47% for youths; 1% to 22% for adults) ( P < .001 for trend for all). The prevalence of glycemic control and use of diabetes technology were lowest in Hispanic, non-Hispanic Black, and Medicaid-insured youths and adults, and differences persisted or increased over time. Conclusions and Relevance In this cross-sectional study, there was a rapid increase in the use of diabetes technology and notable improvements in glycemic control among youths and adults with T1D during the past 15 years. Nonetheless, the prevalence of glycemic control remained low, and racial, ethnic, and socioeconomic differences grew over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Glycemic ControlInsulin Infusion SystemsHealthcare DisparitiesHumansMaleFemaleCross-Sectional StudiesAdultAdolescentUnited StatesMiddle AgedYoung AdultBlood Glucose Self-MonitoringGlycated HemoglobinChildBlood Glucose

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Department of Population Health, Optimal Aging Institute and Division of Epidemiology, New York University Grossman School of Medicine, New York, New York.
  • Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine, Baltimore, Maryland.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Fang, M., Xu, Y., Ballew, S. H., Coresh, J., Echouffo-Tcheugui, J. B., Selvin, E., & Shin, J. I. (2025). Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes. JAMA Network Open, 8(8), e2526353. https://doi.org/10.1001/jamanetworkopen.2025.26353

Vancouver

Fang M, Xu Y, Ballew SH, Coresh J, Echouffo-Tcheugui JB, Selvin E, et al. Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes. JAMA Network Open. 2025;8(8):e2526353. doi:10.1001/jamanetworkopen.2025.26353

BibTeX
@article{Fang2025,
  author = {Fang, Michael and Xu, Yunwen and Ballew, Shoshana H and Coresh, Josef and Echouffo-Tcheugui, Justin B and Selvin, Elizabeth and Shin, Jung-Im},
  title = {Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {8},
  pages = {e2526353},
  doi = {10.1001/jamanetworkopen.2025.26353}
}
Kostenlos starten →